Kevin Shee, MD, PhD

Title(s)Resident, Urology
SchoolSchool of Medicine
Address35 Medical Center Way, #1018
San Francisco CA 94143
Phone415-885-7448
ORCID ORCID Icon0000-0001-5378-7650 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort. Eur Urol Oncol. 2023 Dec 05. Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 38057193.
      View in: PubMed   Mentions:    Fields:    
    2. Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes. Eur Urol Oncol. 2024 Apr; 7(2):222-230. Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR. PMID: 37474400.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. The Fate of Residual Fragments After Percutaneous Nephrolithotomy: Results from the Endourologic Disease Group for Excellence Research Consortium. J Endourol. 2023 06; 37(6):617-622. Wong VKF, Que J, Kong EK, Abedi G, Nimmagadda N, Emmott AS, Paterson RF, Lange D, Lundeen CJ, Nevo A, Shee K, Moore J, Pais V, Sur RL, Bechis SK, Miller NL, Hsi R, Knudsen BE, Sourial M, Humphreys MR, Stern KL, Eisner BH, Chew BH. PMID: 36960704.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging. J Urol. 2023 08; 210(2):281-289. Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carroll PR, Cooperberg MR. PMID: 37099018.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    5. Voided volume may not impact stone outcomes: Review of a large institutional nephrolithiasis cohort. BJUI Compass. 2023 Sep; 4(5):556-561. Shee K, Chan C, Yang H, Sui W, Bowman M, Hamouche F, Charondo LB, Ho S, Chi T, Stoller ML. PMID: 37636214; PMCID: PMC10447213.
      View in: PubMed   Mentions: 2  
    6. Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort. Eur Urol. 2023 07; 84(1):9-12. Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 36870794.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. The endoplasmic reticulum stress response in prostate cancer. Nat Rev Urol. 2022 12; 19(12):708-726. de la Calle CM, Shee K, Yang H, Lonergan PE, Nguyen HG. PMID: 36168057.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. J Urol. 2022 Sep 06; 101097JU0000000000002956. Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 36067374.
      View in: PubMed   Mentions: 1     Fields:    
    9. Identifying Barriers to Successful Completion of Video Telemedicine Visits in Urology. Urology. 2022 11; 169:17-22. Shee K, Liu AW, Yarbrough C, Branagan L, Pierce L, Odisho AY. PMID: 35981658; PMCID: PMC9376975.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    10. Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial. Adv Radiat Oncol. 2022 Sep-Oct; 7(5):100941. Shee K, de la Calle CM, Chang AJ, Wong AC, Feng FY, Gottschalk AR, Carroll PR, Nguyen HG. PMID: 35847550; PMCID: PMC9280039.
      View in: PubMed   Mentions: 1  
    11. Perspectives in primary hyperoxaluria - historical, current and future clinical interventions. Nat Rev Urol. 2022 Mar; 19(3):137-146. Shee K, Stoller ML. PMID: 34880452; PMCID: PMC8652378.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    12. Formal Mentorship as an Opportunity to Expand the Urology Pipeline: Under Represented Trainees Entering Residency (UReTER) Program Evaluation 2020-2021. Urology. 2022 04; 162:108-113. Zheng MY, Overland M, Escobar D, Fakunle M, Li Y, Chu C, Balakrishnan A, Shee K, Washington S, Hampson L. PMID: 34506807.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer. JCO Clin Cancer Inform. 2021 08; 5:912-920. Shee K, Pal SK, Wells JC, Ruiz-Morales JM, Russell K, Dudani S, Choueiri TK, Heng DY, Gore JL, Odisho AY. PMID: 34464153.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance. Urology. 2021 09; 155:91-95. de la Calle CM, Shee K, Chu CE, Cowan JE, Nguyen HG, Carroll PR. PMID: 34118228.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Nedosiran Dramatically Reduces Serum Oxalate in Dialysis-Dependent Primary Hyperoxaluria 1: A Compassionate Use Case Report. Urology. 2021 Oct; 156:e147-e149. Shee K, Ahn J, Hamouche F, Mena J, Chi T, Stoller ML. PMID: 33774044.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    16. Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant. Oncologist. 2021 06; 26(6):467-e924. Schwartz G, Shee K, Romo B, Marotti J, Kisselev A, Lewis L, Miller T. PMID: 33641211; PMCID: PMC8176977.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    17. Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer. Clin Cancer Res. 2020 11 01; 26(21):5668-5681. Axelrod ML, Nixon MJ, Gonzalez-Ericsson PI, Bergman RE, Pilkinton MA, McDonnell WJ, Sanchez V, Opalenik SR, Loi S, Zhou J, Mackay S, Rexer BN, Abramson VG, Jansen VM, Mallal S, Donaldson J, Tolaney SM, Krop IE, Garrido-Castro AC, Marotti JD, Shee K, Miller TW, Sanders ME, Mayer IA, Salgado R, Balko JM. PMID: 32826327; PMCID: PMC7642197.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    18. A rare initial diagnosis of cystinuria during pregnancy. Clin Nephrol. 2020 07; 94(1):53-55. Shee K, Pais V. PMID: 32324129.
      View in: PubMed   Mentions: 1     Fields:    
    19. Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma. J Neurooncol. 2020 Jul; 148(3):473-480. Shee K, Chambers M, Hughes EG, Almiron DA, Deharvengt SJ, Green D, Lefferts JA, Andrew AS, Hickey WF, Tsongalis GJ. PMID: 32583303.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    20. Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer. Breast Cancer Res Treat. 2020 Aug; 182(3):665-677. Chamberlin MD, Wells JD, Shee K, Bean JR, Marotti JD, Wells WA, Trask HW, Kolling FW, Bhatt A, Kaufman PA, Schwartz GN, Gemery JM, McNulty NJ, Tsapakos MJ, Barth RJ, Arrick BA, Gui J, Miller TW. PMID: 32562118; PMCID: PMC7375191.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells. Clin Cancer Res. 2020 07 15; 26(14):3707-3719. Hampsch RA, Wells JD, Traphagen NA, McCleery CF, Fields JL, Shee K, Dillon LM, Pooler DB, Lewis LD, Demidenko E, Huang YH, Marotti JD, Goen AE, Kinlaw WB, Miller TW. PMID: 32321715; PMCID: PMC7367755.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    22. Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer. Cancer Biomark. 2020; 29(1):101-110. Shee K, Seigne JD, Karagas MR, Marsit CJ, Hinds JW, Schned AR, Pettus JR, Armstrong DA, Miller TW, Andrew AS. PMID: 32623385.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy. PLoS One. 2019; 14(11):e0224267. Shee K, Wells JD, Jiang A, Miller TW. PMID: 31682620; PMCID: PMC6827986.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    24. A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition. Clin Cancer Res. 2020 01 01; 26(1):159-170. Shee K, Wells JD, Ung M, Hampsch RA, Traphagen NA, Yang W, Liu SC, Zeldenrust MA, Wang L, Kalari KR, Yu J, Boughey JC, Demidenko E, Kettenbach AN, Cheng C, Goetz MP, Miller TW. PMID: 31558472; PMCID: PMC6942625.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    25. Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer. Mol Oncol. 2019 08; 13(8):1778-1794. Hosford SR, Shee K, Wells JD, Traphagen NA, Fields JL, Hampsch RA, Kettenbach AN, Demidenko E, Miller TW. PMID: 31180176; PMCID: PMC6670014.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    26. Calcifications mimicking ductal carcinoma in situ in a patient with end-stage renal disease. Breast J. 2019 09; 25(5):989-990. Shee K, Veilleux LW, Linos K, Marotti JD. PMID: 31172604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Biomarkers to diagnose metastatic breast carcinoma to the pancreas: A case report and update. Diagn Cytopathol. 2019 Sep; 47(9):912-917. Shee K, Strait AM, Liu X. PMID: 31087784.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer Cells. Cell Biochem Biophys. 2019 Jun; 77(2):109-119. Mast JM, Tse D, Shee K, Lakshmi Kuppusamy M, Kmiec MM, Kálai T, Kuppusamy P. PMID: 31089934.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    29. A novel ex vivo trainer for robotic vesicourethral anastomosis. J Robot Surg. 2020 Feb; 14(1):21-27. Shee K, Koo K, Wu X, Ghali FM, Halter RJ, Hyams ES. PMID: 30689167.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    30. Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing. Am J Pathol. 2019 05; 189(5):956-965. Shee K, Muller KE, Marotti J, Miller TW, Wells WA, Tsongalis GJ. PMID: 30385093; PMCID: PMC6521891.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer. FASEB J. 2019 02; 33(2):1644-1657. Shee K, Jiang A, Varn FS, Liu S, Traphagen NA, Owens P, Ma CX, Hoog J, Cheng C, Golub TR, Straussman R, Miller TW. PMID: 30161001; PMCID: PMC6338642.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    32. Following the crowd: patterns of crowdsourcing on Twitter among urologists. World J Urol. 2019 Mar; 37(3):567-572. Koo K, Shee K, Gormley EA. PMID: 30014160.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med. 2018 03 05; 215(3):895-910. Shee K, Yang W, Hinds JW, Hampsch RA, Varn FS, Traphagen NA, Patel K, Cheng C, Jenkins NP, Kettenbach AN, Demidenko E, Owens P, Faber AC, Golub TR, Straussman R, Miller TW. PMID: 29436393; PMCID: PMC5839765.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    34. The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53. J Biol Chem. 2018 03 23; 293(12):4262-4276. Madan E, Parker TM, Bauer MR, Dhiman A, Pelham CJ, Nagane M, Kuppusamy ML, Holmes M, Holmes TR, Shaik K, Shee K, Kiparoidze S, Smith SD, Park YA, Gomm JJ, Jones LJ, Tomás AR, Cunha AC, Selvendiran K, Hansen LA, Fersht AR, Hideg K, Gogna R, Kuppusamy P. PMID: 29382728; PMCID: PMC5868245.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    35. Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancer. FASEB J. 2018 03; 32(3):1222-1235. Yang W, Hosford SR, Traphagen NA, Shee K, Demidenko E, Liu S, Miller TW. PMID: 29127189; PMCID: PMC5892720.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    36. Trailblazing Precision Oncology for Rare Tumor Subtypes. Oncologist. 2018 02; 23(2):143-144. Shee K, Miller TW. PMID: 29158369; PMCID: PMC5813755.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017 09 15; 357(6356):1156-1160. Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R. PMID: 28912244; PMCID: PMC5727343.
      View in: PubMed   Mentions: 551     Fields:    Translation:HumansAnimalsCells
    38. Pain Management in Penile Prosthetic Surgery: A Review of the Literature. Sex Med Rev. 2018 01; 6(1):162-169. Reinstatler L, Shee K, Gross MS. PMID: 28735683.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    39. Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer. Oncotarget. 2017 Mar 28; 8(13):21806-21817. Hampsch RA, Shee K, Bates D, Lewis LD, Désiré L, Leblond B, Demidenko E, Stefan K, Huang YH, Miller TW. PMID: 28423521; PMCID: PMC5400625.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    40. Practice Makes Perfect: Correlations Between Prior Experience in High-level Athletics and Robotic Surgical Performance Do Not Persist After Task Repetition. J Surg Educ. 2017 Jul - Aug; 74(4):630-637. Shee K, Ghali FM, Hyams ES. PMID: 28087244.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. News Media Analysis of the United States Preventive Services Task Force and American Urological Association Prostate Cancer Screening Guidelines. Urol Pract. 2018 Jan; 5(1):24-30. Koo K, Shee K, Yap RL. PMID: 37300168.
      View in: PubMed   Mentions: 1  
    42. Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin. Case Rep Oncol. 2016 Sep-Dec; 9(3):840-846. Shee K, Kono AT, D'Anna SP, Seltzer MA, Lu X, Miller TW, Chamberlin MD. PMID: 28101033; PMCID: PMC5216250.
      View in: PubMed   Mentions: 2  
    43. Readability analysis of online health information about overactive bladder. Neurourol Urodyn. 2017 Sep; 36(7):1782-1787. Koo K, Shee K, Yap RL. PMID: 27794197.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury. Neurosci Lett. 2016 Sep 06; 630:241-246. Shee K, Lucas A, Flashman LA, Nho K, Tsongalis GJ, McDonald BC, Saykin AJ, McAllister TW, Rhodes CH. PMID: 27478013; PMCID: PMC5002373.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    45. Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer. Clin Cancer Res. 2016 05 01; 22(9):2250-60. Yang W, Hosford SR, Dillon LM, Shee K, Liu SC, Bean JR, Salphati L, Pang J, Zhang X, Nannini MA, Demidenko E, Bates D, Lewis LD, Marotti JD, Eastman AR, Miller TW. PMID: 26733612; PMCID: PMC4854767.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    46. Cell Competition During Growth and Regeneration. Annu Rev Genet. 2015; 49:697-718. Gogna R, Shee K, Moreno E. PMID: 26631518.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    47. The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer. Breast Cancer Res Treat. 2015 Jan; 149(1):69-79. Bean JR, Hosford SR, Symonds LK, Owens P, Dillon LM, Yang W, Shee K, Schwartz GN, Marotti JD, Muller KE, Rosenkranz KM, Barth RJ, Chen VS, Agarwal VR, Miller TW. PMID: 25491778; PMCID: PMC4302040.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    48. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature. 2012 Jul 26; 487(7408):500-4. Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR. PMID: 22763439; PMCID: PMC3711467.
      View in: PubMed   Mentions: 894     Fields:    Translation:HumansCells
    49. Research, collaboration, and open science using web 2.0. J Microbiol Biol Educ. 2010; 11(2):130-4. Shee K, Strong M, Guido NJ, Lue RA, Church GM, Viel A. PMID: 23653712; PMCID: PMC3577171.
      View in: PubMed   Mentions:
    Kevin's Networks
    Concepts (262)
    Derived automatically from this person's publications.
    _
    Co-Authors (32)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _